Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction

Circulation

Volumn 98, Issue 8, 1998, Pages 734-741

  Brener, Sorin J ^a   Barr, Lawrence A ^b   Burchenal, J E B ^c   Katz, Stanley ^d   George, Barry S ^e   Jones, Ancil A ^f   Cohen, Eric D ^g   Gainey, Phillip C ^h   White, Harvey J ⁱ   Barrett Cheek, H ^j   Moses, Jeffrey W ^k   Moliterno, David J ^a   Effron, Mark B ^l   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Midwest Heart Research Foundation   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^e RIVERSIDE METHODIST HOSPITAL   (United States)

^f CROZER CHESTER MEDICAL CENTER   (United States)

^g Baptist Medical Center   (United States)

^h St Joseph Hospital   (United States)

ⁱ Presbyterian Health Services   (United States)

^j High Point Regional Hospital   (United States)

^k LENOX HILL HOSPITAL   (United States)

^l ELI LILLY AND COMPANY   (United States)

more..

Author keywords

Angioplasty; Myocardial infarction; Platelet aggregation inhibitors

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FEMALE; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032566404     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.8.734     Document Type: Article

References (29)

1. Pope CF, Ezekowitz MD, Smith EO, Rapoport S, Glickman M, Sostman HD, Zaret BL. Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy. Am J Cardiol. 1985;55:495-497.
2. Gasperetti CM, Gonias SL, Gimple LW, Powers ER. Platelet activation during coronary angioplasty in humans. Circulation. 1993;88: 2728-2734.
3. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
4. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336:1689-1696.
5. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997;349:1429-1435.
6. Rothbaum D, Linnemeier T, Landin R, Steinmetz E, Hillis J, Hallam C, Noble R, See M. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol. 1987;10:264-272.
7. Ellis S, O'Neill W, Bates E, Walton J, Nabel E, Werns S, Topol E. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1989;13:1251-1259.
8. Kahn J, Rutherford B, McConahay D, Johnson W, Giorgi L, Shimshak T, Ligon R, Hartzler G. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol. 1990;16:1089-1096.
9. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RV, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
10. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
11. de Boer MJ, Hoorntje JC, Ottervanger JP, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol. 1994;23: 1004-1008.
12. Simonton CA, Mark DB, Hinohara T, Rendall DS, Phillips HR, Peter RH, Behar VS, Kong Y, O'Callaghan WG, O'Connor C, Califf RM, Stack RS. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty. J Am Coll Cardiol. 1988;11:698-705.
13. Brodie BR, Grines CL, Ivanhoe R, Knopf W, Taylor G, O'Keefe J, Weintraub RA, Berdan LG, Tcheng JE, Woodlief LH, Califf RM, O'Neill WW. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: final results from the Primary Angioplasty Registry. Circulation. 1994;90:156-162.
14. Gawaz M, Neumann F-JJ, Ott I, Schiessler A, Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 1996;93:229-237.
15. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL, Weisman HF, Topol EJ, EPIC Investigators. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996;77:1045-1051.
16. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ. PROLOG Investigators. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. Am J Cardiol. 1997;79:286-291.
17. Lee PM. Bayesian Statistics: An Introduction. New York, NY: Arnold Publishing; 1989.
18. The IMPACT-II Investigators. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis-II. Lancet. 1997;349:1422-1428.
19. The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty: Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation. 1997;96:1445-1453.
20. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
21. Weaver WD, Simes RJ, Betrieu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F, for the Primary Coronary Angioplasty vs. Thrombolysis Collaboration Group. Primary coronary angioplasty vs. intravenous thrombolysis for treatment of acute myocardial infarction: a quantitative overview of their comparative effectiveness. JAMA. 1997;278:2093-2098.
22. Iwabuchi M, Haruta S, Taguchi A, Ichikawa Y, Genda T, Katai S, Imaoka T, Shimuzu Y, Owa M. Intravascular ultrasound findings after successful primary angioplasty for acute myocardial infarction: predictors of abrupt occlusion. J Am Coll Cardiol. 1997;30:1437-1444.
23. Weinberger I, Fuchs J, Davidson E, Rotenberg Z. Circulating aggregated platelets, number of platelets per aggregate, and platelet size during acute myocardial infarction. Am J Cardiol. 1992;70:981-983.
24. Saito S, Hosokawa G. Primary Palmaz-Schatz stent implantation for acute myocardial infarction: the final results of Japanese PASTA (Primary Angioplasty vs Stent Implantation in AMI in Japan) trial. Circulation. 1997;96(suppl I):I-595. Abstract.
25. Stone GW, Brodie BR, Griffin JJ, Morice M-C, Costantini C, Overlie PA, St Goar FG, Popma JJ, McDonnell J, Jones D, Grines CL. Improved short-term outcomes of primary stenting compared to primary angioplasty in acute myocardial infarction: the PAMI Stent Pilot Trial. Circulation. 1997;96(suppl I):I-594. Abstract.
26. Suryapranata H, Hoorntje JCA, de Boer M-J, Zijlstra F. Randomized comparison of primary stenting with primary balloon angioplasty in acute myocardial infarction. Circulation. 1997;96(suppl I):I-327. Abstract.
27. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Moschi G, Taddeucci E, Dovellini EV, Fazzini PF. A prospective randomized trial of elective stenting in acute myocardial infarction: preliminary results of the FRESCO Study (Florence Randomized Elective Stenting in Acute Coronary Occlusion). Circulation. 1997;96(suppl I):I-327. Abstract.
28. Rodriguez A, Fernandez M, Bemardi V, Mauvecin C, Santaera O, Martinez J, Mele E, Ambrose J, Roubin G, Palacios I, for the GRAMI Investigators. Coronary stents improved hospital results during coronary angioplasty in acute myocardial infarction: preliminary results of a randomized controlled study (GRAMI Trial). J Am Coll Cardiol. 1997;29:221A. Abstract.
29. Neumann F-JJ, Blasini R, Dirschinger J, Claus S, Alt E, Gawaz MP, Fakhoury L, Huppmann R, Schomig A. Intracoronary stent implantation and antithrombotic regimen in acute myocardial infarction: randomized placebo-controlled trial of the fibrinogen receptor antagonist abciximab. Circulation. 1997;96(suppl I):I-399. Abstract.